These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 11785652

  • 1. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
    Peredo R, Sastre G, Serrano J, Hunter Mellado R.
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1025-32. PubMed ID: 11785652
    [Abstract] [Full Text] [Related]

  • 2. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 3. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 4. Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer.
    Stefano R, Agostara B, Calabrò M, Campisi I, Ravazzolo B, Traina A, Miele M, Castagnetta L.
    Ann N Y Acad Sci; 2004 Dec; 1028():463-72. PubMed ID: 15650272
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [Abstract] [Full Text] [Related]

  • 7. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.
    Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL.
    Anticancer Res; 1992 Sep; 12(6B):1965-71. PubMed ID: 1363511
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of steroid receptors and HER 2/neu in breast cancer biopsies of women living in Puerto Rico.
    Colón E, Reyes JS, González Keelan C, Climent-Peris C.
    P R Health Sci J; 2002 Dec; 21(4):299-303. PubMed ID: 12572236
    [Abstract] [Full Text] [Related]

  • 9. HER2/neu expression in relation to clinicopathologic features of breast cancer patients.
    Traina A, Agostara B, Marasà L, Calabrò M, Zarcone M, Carruba G.
    Ann N Y Acad Sci; 2006 Nov; 1089():159-67. PubMed ID: 17261764
    [Abstract] [Full Text] [Related]

  • 10. Prostate-specific antigen value as a marker in breast cancer.
    Narita D, Cimpean AM, Anghel A, Raica M.
    Neoplasma; 2006 Nov; 53(2):161-7. PubMed ID: 16575473
    [Abstract] [Full Text] [Related]

  • 11. Do we need HER-2/neu testing for all patients with primary breast carcinoma?
    Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.
    Cancer; 2003 Dec 15; 98(12):2547-53. PubMed ID: 14669272
    [Abstract] [Full Text] [Related]

  • 12. The significance of HER-2/neu/c-erbB-2 gene amplification in benign and malignant breast disease.
    Supanaranond K, Sukarayodhin S, Tanyakaset M, Balachandra K, Jullaksorn D, Rienkijkarn M, Hoisanka N, Tantivanich S.
    Southeast Asian J Trop Med Public Health; 1997 Sep 15; 28(3):631-40. PubMed ID: 9561622
    [Abstract] [Full Text] [Related]

  • 13. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr 15; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 14. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb 15; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

  • 15. Study of HER2/neu status in Qatari women with breast carcinoma.
    Rasul KI, Mohammaed K, Abdalla AS, Chong-Lopez A, Ahmad MA, Al-Homsi MU, Al-Hassan AM, Al-Alosi AS, Bener A.
    Saudi Med J; 2003 Aug 15; 24(8):832-6. PubMed ID: 12939666
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients.
    Xia W, Chen JS, Zhou X, Sun PR, Lee DF, Liao Y, Zhou BP, Hung MC.
    Clin Cancer Res; 2004 Jun 01; 10(11):3815-24. PubMed ID: 15173090
    [Abstract] [Full Text] [Related]

  • 17. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH, Tai LK, Wong LL, Sethi SK, Koay ES.
    Proteomics; 2005 May 01; 5(7):1797-805. PubMed ID: 15825149
    [Abstract] [Full Text] [Related]

  • 18. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.
    Schmidt M, Lewark B, Kohlschmidt N, Glawatz C, Steiner E, Tanner B, Pilch H, Weikel W, Kölbl H, Lehr HA.
    Breast Cancer Res; 2005 May 01; 7(2):R256-66. PubMed ID: 15743506
    [Abstract] [Full Text] [Related]

  • 19. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT, Byrnes K, Li BD, Turnage RH, Abreo F, Mathis JM, Chu QD.
    J Surg Res; 2007 Jul 01; 141(1):53-9. PubMed ID: 17574038
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G, Beadle G, Thomas S, Mengersen K, Stein S.
    Pathology; 2006 Oct 01; 38(5):391-8. PubMed ID: 17008275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.